These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1644100)

  • 1. Lipoprotein receptors and the control of plasma LDL cholesterol levels.
    Goldstein JL; Brown MS
    Eur Heart J; 1992 Jul; 13 Suppl B():34-6. PubMed ID: 1644100
    [No Abstract]   [Full Text] [Related]  

  • 2. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
    Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia.
    Vohl MC; Szots F; Lelièvre M; Lupien PJ; Bergeron J; Gagné C; Couture P
    Atherosclerosis; 2002 Feb; 160(2):361-8. PubMed ID: 11849659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward personalized medicine in patients with familial hypercholesterolemia.
    Tada H; Takamura M
    Atherosclerosis; 2024 Oct; 397():118522. PubMed ID: 38944546
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.
    Couture P; Brun LD; Szots F; Lelièvre M; Gaudet D; Després JP; Simard J; Lupien PJ; Gagné C
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1007-12. PubMed ID: 9633944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to HMG CoA reductase inhibitors in heterozygous familial hypercholesterolemia due to the 10-kb deletion ("French Canadian mutation") of the LDL receptor gene.
    Karayan L; Qiu S; Betard C; Dufour R; Roederer G; Minnich A; Davignon J; Genest J
    Arterioscler Thromb; 1994 Aug; 14(8):1258-63. PubMed ID: 8049186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolaemia: different perspectives.
    Jones JL; Lakasing E; Archontakis S
    Nurs Stand; 2009 Aug 19-25; 23(50):35-8. PubMed ID: 19736707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.
    Leitersdorf E; Eisenberg S; Eliav O; Friedlander Y; Berkman N; Dann EJ; Landsberger D; Sehayek E; Meiner V; Wurm M
    Circulation; 1993 Apr; 87(4 Suppl):III35-44. PubMed ID: 8462179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A keen eye for risk.
    Ford TJ; Rocchiccioli P
    BMJ; 2018 Feb; 360():j5884. PubMed ID: 29419393
    [No Abstract]   [Full Text] [Related]  

  • 13. Lowering plasma cholesterol by raising LDL receptors.
    Brown MS; Goldstein JL
    N Engl J Med; 1981 Aug; 305(9):515-7. PubMed ID: 6265781
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pravastatin in relation to low density lipoprotein receptor activity.
    Hayashi H; Naito C; Ito H; Kawamura M; Miyazaki S
    Curr Med Res Opin; 1990; 12(2):100-7. PubMed ID: 2118022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of familial hypercholesterolaemia in Morocco.
    El Messal M; Aït Chihab K; Chater R; Loutfi M; Kettani A; Hafidi A; Adlouni A
    Acta Cardiol; 2006 Oct; 61(5):551-5. PubMed ID: 17117756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
    Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of high total cholesterol with coronary heart disease mortality differs among subject populations--familial hypercholesterolemia as a key concept.
    Okuyama H; Ichikawa Y; Sun Y; Hamazaki T; Lands WE
    World Rev Nutr Diet; 2007; 96():19-36. PubMed ID: 17167278
    [No Abstract]   [Full Text] [Related]  

  • 18. R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia.
    Rabès JP; Varret M; Devillers M; Aegerter P; Villéger L; Krempf M; Junien C; Boileau C
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E76-82. PubMed ID: 11031227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.